Table 2

Difference in composite rate of high-intensity end-of-life care by primary outpatient oncologist type

CohortModel 1: SimpleModel 2: Multivariable linearModel 3: Multivariable logistic
nPercent of intense end-of-life care (%)95% CIP valuePercent of intense end-of-life care (%)95% CIP valueOR95% CIP value
Entire cohort*
Medical oncologist770556.5155.35 to 57.660.02856.5655.4 to 57.730.0181Ref.0.018
Gynecologic oncologist448454.0652.2 to 55.9253.9752.21 to 55.720.900.82 to 0.98
Propensity score-matched cohort, with replacement†
Medical oncologist276857.5155.59 to 59.440.01257.4655.52 to 59.390.0111Ref.0.011
Gynecologic oncologist448454.0652.2 to 55.9254.152.38 to 55.810.870.78 to 0.97
Propensity score-matched cohort, without replacement‡
Medical oncologist448456.9155.40 to 58.420.02056.7855.27 to 58.290.0271Ref.0.027
Gynecologic oncologist448454.0652.2 to 55.9254.1952.46 to 55.920.900.82 to 0.99
  • *Covariates included in the multivariable regression models: age at death, race, ethnicity, marital status, median income of residential zip code at death, percent of people with less than a high school education in the residential zip code at death, SEER registry at death, residential urban status at death, year of diagnosis, year of death, cancer site, cause of death, stage at diagnosis, Medicare/Medicaid dual eligibility at death, and CCI at death.

  • †Covariates included in the multivariable regression models: SEER registry at death, cause of death, and CCI at death.

  • ‡Covariates included in the multivariable regression models: SEER registry at death, cause of death, and year of death.

  • CCI, Charlson Comorbidity Index; CI, confidence interval; OR, odds ratio; Ref., reference; SEER, Surveillance, Epidemiology and End Results .